ChromoGenics AB (CHRO.ST)

SEK 9.8

(0.2%)

Total Liabilities Summary of ChromoGenics AB

ChromoGenics AB's latest annual total liabilities in 2023 was 93.98 Million SEK , up 3.26% from previous year.
ChromoGenics AB's latest quarterly total liabilities in 2024 Q1 was 104.55 Million SEK , up 11.25% from previous quarter.
ChromoGenics AB reported annual total liabilities of 91.01 Million SEK in 2022, down -11.42% from previous year.
ChromoGenics AB reported annual total liabilities of 102.74 Million SEK in 2021, up 10.59% from previous year.
ChromoGenics AB reported quarterly total liabilities of 58.77 Million SEK for 2024 Q2, down -43.79% from previous quarter.
ChromoGenics AB reported quarterly total liabilities of 92.49 Million SEK for 2023 Q2, up 1.59% from previous quarter.

Annual Total Liabilities Chart of ChromoGenics AB (2023 - 2013)

Historical Annual Total Liabilities of ChromoGenics AB (2023 - 2013)

Year	Total Liabilities	Total Liabilities Growth
2023	93.98 Million SEK	3.26%
2022	91.01 Million SEK	-11.42%
2021	102.74 Million SEK	10.59%
2020	92.9 Million SEK	3.86%
2019	89.44 Million SEK	3.33%
2018	86.56 Million SEK	35.43%
2017	63.91 Million SEK	-9.63%
2016	70.72 Million SEK	27.36%
2015	55.53 Million SEK	10.6%
2014	50.2 Million SEK	24.84%
2013	40.21 Million SEK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	104.55 Million SEK	11.25%
2024 Q2	58.77 Million SEK	-43.79%
2023 Q2	92.49 Million SEK	1.59%
2023 Q3	99.38 Million SEK	7.45%
2023 FY	93.98 Million SEK	3.26%
2023 Q1	91.05 Million SEK	0.04%
2023 Q4	93.98 Million SEK	-5.44%
2022 Q3	90.65 Million SEK	-11.86%
2022 Q4	91.01 Million SEK	0.4%
2022 FY	91.01 Million SEK	-11.42%
2022 Q1	111.35 Million SEK	8.39%
2022 Q2	102.85 Million SEK	-7.64%
2021 Q2	106.59 Million SEK	14.15%
2021 Q1	93.38 Million SEK	0.51%
2021 Q3	106.17 Million SEK	-0.4%
2021 FY	102.74 Million SEK	10.59%
2021 Q4	102.74 Million SEK	-3.23%
2020 Q2	90.2 Million SEK	0.13%
2020 Q1	90.08 Million SEK	0.71%
2020 FY	92.9 Million SEK	3.86%
2020 Q4	92.9 Million SEK	5.1%
2020 Q3	88.39 Million SEK	-2.0%
2019 Q3	90.31 Million SEK	-31.7%
2019 Q4	89.44 Million SEK	-0.96%
2019 FY	89.44 Million SEK	3.33%
2019 Q1	79.48 Million SEK	-8.18%
2019 Q2	132.22 Million SEK	66.35%
2018 Q2	70.5 Million SEK	2.99%
2018 Q4	86.56 Million SEK	23.44%
2018 FY	86.56 Million SEK	35.43%
2018 Q1	68.45 Million SEK	7.1%
2018 Q3	70.12 Million SEK	-0.54%
2017 Q2	59.52 Million SEK	-12.6%
2017 Q1	68.1 Million SEK	-3.71%
2017 FY	63.91 Million SEK	-9.63%
2017 Q4	63.91 Million SEK	11.33%
2017 Q3	57.41 Million SEK	-3.55%
2016 Q3	61.22 Million SEK	0.0%
2016 FY	70.72 Million SEK	27.36%
2016 Q4	70.72 Million SEK	15.51%
2016 Q1	- SEK	-100.0%
2015 Q4	55.53 Million SEK	0.0%
2015 FY	55.53 Million SEK	10.6%
2014 FY	50.2 Million SEK	24.84%
2013 FY	40.21 Million SEK	0.0%

Peer Total Liabilities Comparison of ChromoGenics AB

Name	Total Liabilities	Total Liabilities Difference
Balco Group AB	519.25 Million SEK	81.9%
Byggmax Group AB (publ)	4.54 Billion SEK	97.93%
Ecoclime Group AB (publ)	99.8 Million SEK	5.831%
FM Mattsson Mora Group AB (publ)	755.91 Million SEK	87.567%
Inwido AB (publ)	4.48 Billion SEK	97.906%
Lindab International AB (publ)	6.32 Billion SEK	98.513%
NIBE Industrier AB (publ)	37.89 Billion SEK	99.752%
Nordic Waterproofing Holding AB (publ)	1.85 Billion SEK	94.935%
Polyplank AB (publ)	24.21 Million SEK	-288.071%
Svedbergs i Dalstorp AB (publ)	1.94 Billion SEK	95.161%
Systemair AB (publ)	4.13 Billion SEK	97.729%